Prof. William Gallagher, BSc PhD CBiol MSB, Professor of Cancer Biology in the UCD School of Biomolecular & Biomedical Science, UCD Conway Institute at University College Dublin and a leading figure in translational oncology innovation. A results-driven academic and entrepreneur, he currently serves as the Deputy Director of Precision Oncology Ireland (POI), a national Strategic Partnership Programme focused on developing next-generation diagnostics and treatment strategies for cancer. Prof. Gallagher previously directed the prestigious UCD Conway Institute of Biomolecular and Biomedical Research (2016-2021) and is a key Co-lead for the emerging All-Island Cancer Research Institute, demonstrating his commitment to large-scale, collaborative research delivery. With a core focus on translating complex transcriptomic and proteomic data into clinically relevant biomarker assays for breast and prostate cancer, his translational expertise is evidenced by his role as Co-founder and Chief Scientific Officer of OncoAssure Ltd. In 2021, another molecular diagnostics company that he co-founded, OncoMark Ltd., was acquired in 2021 by Danaher Corp. His success in attracting funding is unparalleled, having secured over €80 million since 1999. This includes coordination of major EU framework initiatives and the Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT, ensuring our research delivers assertive, real-world impact for the life sciences sector in Ireland.
Innovation Training for ARC Hub for Therapeutics Translational Researchers
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
